The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Certara’s AI strategy and FDA-aligned offerings fuel growth across drug discovery and trials, with expanding margins. Read ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Human-Based Lab Models: The FDA will promote the use of lab-grown human “organoids” and organ-on-a-chip systems that mimic ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

The global antibody market is poised for remarkable expansion over the next decade, with market estimates predicting a significant rise in valuation from USD 266.83 billion in 2024 to an impressive ...

The U.S. Food and Drug Administration is replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

But Youle’s dismissal, along with 10 others at the NIH’s National Institute of Neurological Disorders and Stroke, underscores ...

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute ...

Navrogen, Inc. has announced groundbreaking advancements in monoclonal antibody (mAb) and antibody-drug conjugate (ADC) ...